Pivot Magazine – Out of Breath
A Canadian company invented a non-invasive breath test that will detect breast cancer, neurodegenerative diseases and respiratory illnesses.
A Canadian company invented a non-invasive breath test that will detect breast cancer, neurodegenerative diseases and respiratory illnesses.
Blow into a machine to detect cancer. This is the principle of a new tool, developed locally by the medical technology company Breathe BioMedical, which is similar to the breathalyzer. If its effectiveness is…
Seeking an accessible diagnostic medium, researchers are rooting through the concoction of compounds in exhaled breath vapor for the metabolic manifestations of disease.
Technologies in development could make cancer screening less of a hassle and more widely available. After his godmother and his business partner’s mother both died of breast cancer, Rubens Fernando Mendrone made a radical…
Disclaimer
This website contains forward-looking information. Forward-looking information is based on the current estimates, opinions and beliefs of Breathe BioMedical, as well as various assumptions and information currently available to Breathe BioMedical. Although Breathe BioMedical believes the expectations expressed in such forward-looking information are based on reasonable assumptions, there can be no assurance that such forward-looking information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. Key assumptions upon which the forward-looking information is based include, but are not limited to, assumptions in connection with future growth potential, access to capital and market conditions, results of operations, results of clinical studies, regulatory approval processes and timelines by Federal Drug Administration and Health Canada, commercial partnerships, clinical study results by principal investigators independent of Picomole and published results by accredited medical journals, future prospects and opportunities, applicable legislative and regulatory regimes, and that key members of management will remain in place.
Forward-looking information involves known and unknown risks and uncertainties and other factors which may cause the actual results, performance or achievements of Breathe BioMedical to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. These factors include, the ability of Breathe BioMedical to operate as a going concern; development and operating risks; global financial volatility; and reliance on key members of management. Although Breathe BioMedical has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information will prove to be accurate and our actual results, performance, achievements and financial condition may differ materially from those indicated in the forward-looking information or implied by such forward-looking information. Therefore, you should not rely on any of this forward-looking information.